Cargando…
Next-generation sequencing for MRD monitoring in B-lineage malignancies: from bench to bedside
Minimal residual disease (MRD) is considered the strongest relevant predictor of prognosis and an effective decision-making factor during the treatment of hematological malignancies. Remarkable breakthroughs brought about by new strategies, such as epigenetic therapy and chimeric antigen receptor-T...
Autores principales: | Deng, Xinyue, Zhang, Meilan, Zhou, Jianfeng, Xiao, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440501/ https://www.ncbi.nlm.nih.gov/pubmed/36057673 http://dx.doi.org/10.1186/s40164-022-00300-2 |
Ejemplares similares
-
Next-Generation Sequencing: The Translational Medicine Approach from “Bench to Bedside to Population”
por: Beigh, Mohammad Muzafar
Publicado: (2016) -
Bench-to-bedside review: An approach to hemodynamic monitoring - Guyton at the bedside
por: Magder, Sheldon
Publicado: (2012) -
Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation
por: Liang, Emily C., et al.
Publicado: (2023) -
Malignant pleural effusion: from bench to bedside
por: Psallidas, Ioannis, et al.
Publicado: (2016) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)